
Historic Day for Lupus Patients – Benlysta gets FDA approval
FDA approves Benlysta to treat lupus First new lupus drug approved in 56 years The U.S. Food and Drug Administration today approved Benlysta (belimumab) to treat patients with active, autoantibody-positive lupus (systemic lupus erythematosus) who are receiving standard therapy, includi
[ 7 comments ] | [ read more ]